SCHEMBL6176863

SCHEMBL6176863

CC(=NO)C(=Cc1cccc(Cl)c1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.50
KDM4E B2RXH2 4/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
NTSR1 P30989 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ALDH1A1 P00352 3/20 0.47
KMT2A Q03164 3/20 0.47
POLB P06746 1/20 0.47
PKM P14618 1/20 0.47
MAOB P27338 1/20 0.46
MEN1 O00255 2/20 0.43
AKR1C1 Q04828 3/20 0.42
AKR1C2 P52895 2/20 0.42
GAA P10253 2/20 0.41
CHRM5 P08912 1/20 0.41
TRPA1 O75762 1/20 0.41
FBP1 P09467 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176859 1.00 AKR1C3 (0.50) AKR1C3KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL6169877 0.84 AKR1C1 (0.55) AKR1C3KDM4ELMNAMAPTNPSR1
SCHEMBL6169883 0.84 AKR1C1 (0.55) AKR1C3KDM4ELMNAMAPTNPSR1
SCHEMBL6168232 0.82 AKR1C3 (0.59) AKR1C3KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL6168237 0.82 AKR1C3 (0.59) AKR1C3KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL29293786 0.78 ALDH1A1 (0.54) AKR1C3KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL6516511 0.74 AKR1C3 (0.44) AKR1C3KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL6516514 0.74 AKR1C3 (0.44) AKR1C3KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL20415245 0.73 AKR1C3 (0.50) AKR1C3KDM4ELMNAMAPTSMN1; SMN2
SCHEMBL20415242 0.73 AKR1C3 (0.50) AKR1C3KDM4ELMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed